OGI
Organigram Global Inc. Healthcare - Drug Manufacturers - Specialty & Generic Investor Relations →
Organigram Global Inc. (OGI) closed at $1.36 as of 2026-03-20, trading 34.7% below its 200-week moving average of $2.08. This places OGI in the extreme value zone. The stock is currently moving closer to the line, down from -32.9% last week. With a 14-week RSI of 28, OGI is in oversold territory.
Trading volume is running at 0.5x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.37 ratio) is neutral — neither side is clearly dominating.
Over the past 308 weeks of data, OGI has crossed below its 200-week moving average 4 times. On average, these episodes lasted 74 weeks. The average one-year return after crossing below was -0.8%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $188 million, OGI is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at 4.6%. The stock trades at 0.7x book value.
Share count has increased 80.0% over three years, indicating dilution.
Over the past 6 years, a hypothetical investment of $100 in OGI would have grown to $23, compared to $243 for the S&P 500. OGI has returned -21.9% annualized vs 15.9% for the index, underperforming the broader market over this period.
Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: OGI vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After OGI Crosses Below the Line?
Across 4 historical episodes, buying OGI when it crossed below its 200-week moving average produced an average return of -21.8% after 12 months (median -47.0%), compared to +12.5% for the S&P 500 over the same periods. 25% of those episodes were profitable after one year. After 24 months, the average return was -63.5% vs +15.5% for the index.
Each line shows $100 invested at the moment OGI crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
OGI has crossed below its 200-week MA 4 times with an average 1-year return of +-0.8% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Apr 2020 | Feb 2021 | 41 | 65.8% | +77.0% | -77.3% |
| Mar 2021 | Mar 2021 | 1 | 1.7% | -48.5% | -87.3% |
| Apr 2021 | May 2021 | 6 | 12.5% | -31.0% | -86.5% |
| Jun 2021 | Ongoing | 247+ | 83.7% | Ongoing | -87.5% |
| Average | 74 | — | +-0.8% | — |
Frequently Asked Questions
Is OGI below its 200-week moving average?
Yes. As of 2026-03-20, Organigram Global Inc. (OGI) is trading 34.7% below its 200-week moving average of $2.08. The current price is $1.36.
What is OGI's 200-week moving average price?
Organigram Global Inc.'s 200-week moving average is $2.08 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when OGI drops below its 200-week moving average?
OGI has crossed below its 200-week moving average 4 times in our data. The average one-year return after these crossings was -0.8%, meaning the dips were not reliable buying signals for this particular stock. These episodes lasted 74 weeks on average.
Is OGI a good value right now?
Here's what our data says about OGI as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 28 (oversold). Free cash flow is currently negative. Return on equity is 4.6%. Price-to-book is 0.7x. This is not a buy or sell recommendation — always do your own research.
How does OGI compare to the S&P 500?
Over the past 6 years, $100 invested in OGI would have grown to $23, compared to $243 for the S&P 500. That's -21.9% annualized vs 15.9% for the index. OGI has underperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20